BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37829123)

  • 21. Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.
    Chen X; Wang H; Liao HJ; Hu W; Gewin L; Mernaugh G; Zhang S; Zhang ZY; Vega-Montoto L; Vanacore RM; Fässler R; Zent R; Pozzi A
    J Clin Invest; 2014 Aug; 124(8):3295-310. PubMed ID: 24983314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular domain of the transforming growth factor-beta receptor negatively regulates ligand-independent receptor activation.
    Zhu HJ; Sizeland AM
    J Biol Chem; 1999 Oct; 274(41):29220-7. PubMed ID: 10506179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-β receptor type II costameric localization in cardiomyocytes and host cell TGF-β response is disrupted by Trypanosoma cruzi infection.
    Calvet CM; Silva TA; DE Melo TG; DE Araújo-Jorge TC; Pereira MC
    Parasitology; 2016 May; 143(6):704-15. PubMed ID: 26996782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.
    Chen G; Ghosh P; Longo DL
    Mol Cancer Res; 2011 Jan; 9(1):78-89. PubMed ID: 21131601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
    Zhang H; Liu ZG; Hua XX
    Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus.
    Song HM; Fong KD; Nacamuli RP; Warren SM; Fang TD; Mathy JA; Cowan CM; Aalami OO; Longaker MT
    Plast Reconstr Surg; 2004 May; 113(6):1685-97. PubMed ID: 15114130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.
    Bollard CM; Rössig C; Calonge MJ; Huls MH; Wagner HJ; Massague J; Brenner MK; Heslop HE; Rooney CM
    Blood; 2002 May; 99(9):3179-87. PubMed ID: 11964281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
    Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
    J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling.
    Villarreal MM; Kim SK; Barron L; Kodali R; Baardsnes J; Hinck CS; Krzysiak TC; Henen MA; Pakhomova O; Mendoza V; O'Connor-McCourt MD; Lafer EM; López-Casillas F; Hinck AP
    Biochemistry; 2016 Dec; 55(49):6880-6896. PubMed ID: 27951653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric granulocyte/macrophage colony-stimulating factor/transforming growth factor-beta (TGF-beta) receptors define a model system for investigating the role of homomeric and heteromeric receptors in TGF-beta signaling.
    Anders RA; Leof EB
    J Biol Chem; 1996 Sep; 271(36):21758-66. PubMed ID: 8702972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor.
    Atfi A; Dumont E; Colland F; Bonnier D; L'helgoualc'h A; Prunier C; Ferrand N; Clément B; Wewer UM; Théret N
    J Cell Biol; 2007 Jul; 178(2):201-8. PubMed ID: 17620406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.
    Xavier S; Vasko R; Matsumoto K; Zullo JA; Chen R; Maizel J; Chander PN; Goligorsky MS
    J Am Soc Nephrol; 2015 Apr; 26(4):817-29. PubMed ID: 25535303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Splice Variant of Human TGF-β Type II Receptor Encodes a Soluble Protein and Its Fc-Tagged Version Prevents Liver Fibrosis
    Bertolio MS; La Colla A; Carrea A; Romo A; Canziani G; Echarte SM; Campisano S; Barletta GP; Monzon AM; Rodríguez TM; Chisari AN; Dewey RA
    Front Cell Dev Biol; 2021; 9():690397. PubMed ID: 34568316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
    Tazat K; Hector-Greene M; Blobe GC; Henis YI
    Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D; Tang XM; Ma C; Chegini N
    Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling.
    Park J; Lee SY; Ooshima A; Yang KM; Kang JM; Kim YW; Kim SJ
    J Mol Med (Berl); 2013 Nov; 91(11):1273-84. PubMed ID: 24072041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.